Diabetes Seen as Biggest Driver in Increased Spending on Drugs

Lilly's Humalog

| Jun 15, 2011

Statistics from the 2011 Medco Drug Report show that diabetes drugs accounted for 16.1 percent of the overall increase in U.S. spending on therapeutic drugs in 2010. The report states that the increase is due to the growing number of Americans who have diabetes.

The federal government estimates that almost 26 million U.S. residents had diabetes in 2010, and another 79 million had prediabetes-about 35 percent of all U.S. adults. It expects the number of people with diabetes and prediabetes to reach 52 percent of the adult population by 2020.

Within the category of diabetes drugs, insulin accounted for 36 percent of overall costs and 63 percent of total growth. The category generating the second largest percentage of spending growth was respiratory drugs, which grew at 15.1 percent. That category includes drugs for asthma, chronic bronchitis, and emphysema.  

New Jersey-based Medco Health Solutions, Inc., is a healthcare company that provides pharmacy services for private and public employers, health plans, labor unions, government agencies, and individuals served by Medicare Part D prescription drug plans-in all, an estimated 65 million people. Its 2009 revenues were reported to be just under $60 billion.


Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Insulin, Medco Drug Report, Pre-Diabetes

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (5)

You May Also Be Interested In...


Posted by Anonymous on 15 June 2011

Type 1's will always need insulin. Perhaps the article really means the explosion of Type 2's? There are several research studies trying to find the real triggers for Type 2 and not the stereotypical overweight slob that Type 2's are labelled. All overweight people would be Type 2 if there wasn't more to the reasons why this happens.

Posted by Rick on 16 June 2011

are the drug companies complaining? i don't think we'll see a cure anytime soon.

Posted by Anonymous on 16 June 2011

I agree with Rick. The article should be called "Reasons Why We Will Never Have a Cure"

We might be shocked and optimistic, but someone somewhere is celebrating over these statistics...and I am guessing they are not diabetic.

Posted by Anonymous on 16 June 2011

And here is the main reason why there is no cure for Type 1 or Type 2 diabetes. There is way too much money to made. Just think about not just insulin, but the means to inject it in the body, supplies for checking blood glucose, then all and many many complications that go along with any type of diabetes. Also by now you would think that would be form of oral insulin instead of just injectable.Susan

Posted by Feinman on 17 June 2011

Might this have anything to do with another outstanding DiabetesHealth article: http://www.diabeteshealth.com/read/2011/05/24/7158/maple-syrup-a-sweet-surprise/

Allow me to quote from that article:

"Meet the latest superfood: maple syrup. Wait a minute...maple syrup? The super-sugary stuff poured on pancakes and waffles and used to glaze hams? That maple syrup?

"That's right. Researchers from the University of Rhode Island have discovered that the syrup-produced in the northeastern United States and Canada--contains numerous compounds with real health benefits."

I'm afraid that this leaves me uncharacteristically speechless. Anyway, the article goes on to point out:

"The results must have pleased the research's sponsors. Funds for the scientific work came from the Federation of Quebec Maple Syrup Producers and Agriculture and Agri-Food Canada."

The results must have also pleased the producers of the drugs in the article above. They must also have pleased the American Diabetes Association who have built a business on encouraging people with diabetes to fulfill their "right" to have sucrose as long as it is "covered with insulin."

One question is whether the editors of DiabetesHealth were pleased. There are a million articles about diabetes -- especially if you count non-peer-reviewed presentations at meetings. To pick this out in order to make people infuriated and increase market share -- or whatever was the motivation -- did this please the editors. I know, I'm getting carried away but we're all in this together and at some point you have to recognize dangerous nonsense for what it is.

Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.